4.2 Review

Lithium: An Old Drug for New Therapeutic Strategy for Alzheimer's Disease and Related Dementia

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Neurosciences

Lithium Provides Broad Therapeutic Benefits in an Alzheimer's Disease Mouse Model

Alyssa L. Wiseman et al.

Summary: This study investigated the stabilizing effect of lithium on calcium signaling abnormalities in hippocampal neurons and its subsequent effects on AD neuropathology and synaptic plasticity. The results showed that lithium treatment reduced aberrant calcium signaling and restored nNOS and p-tau levels, as well as enhanced short-term synaptic plasticity in 3xTg-AD mice. Lithium could be an effective treatment or co-therapeutic for AD.

JOURNAL OF ALZHEIMERS DISEASE (2023)

Article Medicine, General & Internal

Lecanemab in Early Alzheimer's Disease

Christopher H. van Dyck et al.

Summary: Lecanemab, a humanized monoclonal antibody, reduced amyloid markers and showed improvement in cognition and function in early Alzheimer's disease patients. However, it also resulted in adverse events. Longer trials are needed to determine its efficacy and safety in early Alzheimer's disease.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Article Clinical Neurology

Pathogenesis of sporadic Alzheimer's disease by deficiency of NMDA receptor subunit GluN3A

Weiwei Zhong et al.

Summary: The study suggests that GluN3A deficiency may lead to Alzheimer's disease by causing neuronal hyperactivity, elevated intracellular Ca2+ levels, neuroinflammation, impaired synaptic integrity/plasticity, and neuronal loss. It also proposes GluN3A as an early biomarker and a therapeutic target independent of amyloid-beta/tau pathology in AD.

ALZHEIMERS & DEMENTIA (2022)

Article Neurosciences

Making the Case for Accelerated Withdrawal of Aducanumab

Peter Whitehouse et al.

Summary: The FDA's controversial approval of aducanumab for Alzheimer's disease in June 2021 has raised significant concerns due to its lack of clinical efficacy evidence, safety issues, and high cost. In December 2021, an international group recommended the withdrawal of FDA approval for aducanumab, supporting the filing of a formal Citizen Petition by the Right Care Alliance.

JOURNAL OF ALZHEIMERS DISEASE (2022)

Review Clinical Neurology

Amyloid-Related Imaging Abnormalities With Anti-amyloid Antibodies for the Treatment of Dementia Due to Alzheimer's Disease

Charles G. Withington et al.

Summary: Second-generation anti-amyloid monoclonal antibodies are a potential treatment option for early-stage Alzheimer's disease, but they come with the risk of amyloid-related imaging abnormality (ARIA). ARIA can cause symptoms such as headache and visual disturbances, and in some cases, it can be fatal. The dosage, baseline MRI results, and presence of cerebrovascular disease should be taken into consideration when using these drugs.

FRONTIERS IN NEUROLOGY (2022)

Review Biochemistry & Molecular Biology

Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer's Disease, Lithium, and Autophagy

Odeya Damri et al.

Summary: Lithium, a prototype mood stabilizer, is being considered for repurposing as a drug for neurodegenerative diseases due to its neuroprotective properties. Its mechanism of action involves modulation of homeostatic mechanisms and inhibition of enzymes such as IMPase and GSK-3, resulting in a range of intracellular responses. Studies in cells, animal models, and patients have shown promise for the use of lithium in the treatment of Alzheimer's disease.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Materials Science, Biomaterials

Enhanced Neuronal Activity and Asynchronous Calcium Transients Revealed in a 3D Organoid Model of Alzheimer's Disease

Juan Yin et al.

Summary: The study successfully generated Alzheimer's disease (AD) models in a human genetic context using self-organizing 3D brain organoids, characterizing them through morphology analysis, neuronal activity, drug sensitivity, and neural apoptosis to find that the AD organoids recapitulated AD-like pathology effectively.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2021)

Review Cell Biology

GSK-3 and Tau: A Key Duet in Alzheimer's Disease

Carmen Laura Sayas et al.

Summary: GSK-3 is a crucial player in AD pathology, contributing to the hyperphosphorylation of tau protein and involvement in various neuronal processes that are dysregulated during AD pathogenesis. Targeting GSK-3 or GSK-3-phosphorylated tau could hold potential for developing AD therapies.
Review Cell Biology

Effects of monoclonal antibodies against amyloid-β on clinical and biomarker outcomes and adverse event risks: A systematic review and meta-analysis of phase III RCTs in Alzheimer's disease

Konstantinos Avgerinos et al.

Summary: Monoclonal antibodies targeting A beta have shown small clinical improvements and large biomarker improvements in Alzheimer's disease patients. However, they also increase the risk of adverse events such as ARIA.

AGEING RESEARCH REVIEWS (2021)

Article Chemistry, Multidisciplinary

Tuning Protein Dynamics to Sense Rapid Endoplasmic-Reticulum Calcium Dynamics

Xiaonan Deng et al.

Summary: The study introduces a novel ER-targeted calcium indicator, R-CatchER, with superior kinetics in various cell types, revealing the spatiotemporal dynamics and functional cooperativity of ER Ca2+ and proposing a design principle for genetically encoded Ca2+ indicators.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Review Biochemistry & Molecular Biology

Autophagy and Tau Protein

Tadanori Hamano et al.

Summary: Neurofibrillary tangles and senile plaques are pathological hallmarks of Alzheimer's disease, with autophagy disturbances being implicated in tau protein accumulation. Therapeutic strategies focusing on autophagic modulation may hold promise in AD treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Geriatrics & Gerontology

Combined Neuroprotective Strategies Blocked Neurodegeneration and Improved Brain Function in Senescence-Accelerated Mice

Helena Nascimento Malerba et al.

Summary: This study found that the combination of microdose lithium and enriched environment can effectively promote healthy aging in senescence accelerated mice, by delaying the onset of neurodegenerative diseases and improving memory.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Review Environmental Sciences

The Present State of Lithium for the Prevention of Dementia Related to Alzheimer's Dementia in Clinical and Epidemiological Studies: A Critical Review

Nobuyoshi Ishii et al.

Summary: This review article hypothesized that lithium at trace to standard levels may be effective for dementia prevention, based on several clinical and epidemiological studies. However, there is a scarcity of studies on trace lithium levels, and the existing studies on standard lithium levels are insufficient to establish its efficacy for dementia prevention.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Review Neurosciences

Lithium as a Treatment for Alzheimer's Disease: The Systems Pharmacology Perspective

Harald Hampel et al.

JOURNAL OF ALZHEIMERS DISEASE (2019)

Article Biochemistry & Molecular Biology

The Synaptic Autophagy Cycle

Ori J. Lieberman et al.

JOURNAL OF MOLECULAR BIOLOGY (2019)

Article Neurosciences

The New News about Lithium: An Underutilized Treatment in the United States

Robert M. Post

NEUROPSYCHOPHARMACOLOGY (2018)

Review Biochemistry & Molecular Biology

Inositol 1,4,5-trisphosphate receptors and neurodegenerative disorders

Polina A. Egorova et al.

FEBS JOURNAL (2018)

Review Neurosciences

Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease

Fuyuki Kametani et al.

FRONTIERS IN NEUROSCIENCE (2018)

Article Psychology, Clinical

Association Between Lithium Use and Risk of Alzheimer's Disease

Chin Cheng et al.

JOURNAL OF CLINICAL PSYCHIATRY (2017)

Article Psychiatry

Association of Lithium in Drinking Water With the Incidence of Dementia

Lars Vedel Kessing et al.

JAMA PSYCHIATRY (2017)

Article Anatomy & Morphology

Stereological investigation of the CA1 pyramidal cell layer in untreated and lithium-treated 3xTg-AD and wild-type mice

Evelin L. Schaeffer et al.

ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER (2017)

Review Neurosciences

The Amyloid Cascade Hypothesis in Alzheimer's Disease: It's Time to Change Our Mind

Roberta Ricciarelli et al.

CURRENT NEUROPHARMACOLOGY (2017)

Article Clinical Neurology

Lithium, a Therapy for AD: Current Evidence from Clinical Trials of Neurodegenerative Disorders

Orestes V. Forlenza et al.

CURRENT ALZHEIMER RESEARCH (2016)

Review Psychiatry

Lithium side effects and toxicity: prevalence and management strategies

Michael Gitlin

INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS (2016)

Review Biochemistry & Molecular Biology

Ca2+ homeostasis and endoplasmic reticulum (ER) stress: An integrated view of calcium signaling

Joachim Krebs et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Review Biochemistry & Molecular Biology

Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics

M. Alda

MOLECULAR PSYCHIATRY (2015)

Article Neurosciences

The case for rejecting the amyloid cascade hypothesis

Karl Herrup

NATURE NEUROSCIENCE (2015)

Review Biochemistry & Molecular Biology

A New Avenue for Lithium: Intervention in Traumatic Brain Injury

Peter R. Leeds et al.

ACS CHEMICAL NEUROSCIENCE (2014)

Review Biochemistry & Molecular Biology

Lithium and Autophagy

Yumiko Motoi et al.

ACS CHEMICAL NEUROSCIENCE (2014)

Review Psychiatry

Standard and trace-dose lithium: A systematic review of dementia prevention and other behavioral benefits

Sivan Mauer et al.

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2014)

Review Neurosciences

GSK-3β, a pivotal kinase in Alzheimer disease

Maria Llorens-Martin et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2014)

Review Neurosciences

Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's Disease

Gary P. Morris et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)

Article Clinical Neurology

Microdose Lithium Treatment Stabilized Cognitive Impairment in Patients with Alzheimer’s Disease

Marielza Andrade Nunes et al.

Current Alzheimer Research (2013)

Article Clinical Neurology

Four weeks lithium treatment alters neuronal dendrites in the rat hippocampus

Seong S. Shim et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)

Review Neurosciences

GSK3 and Tau: Two Convergence Points in Alzheimer's Disease

Felix Hernandez et al.

JOURNAL OF ALZHEIMERS DISEASE (2013)

Review Neurosciences

Short-term forms of presynaptic plasticity

Diasynou Fioravante et al.

CURRENT OPINION IN NEUROBIOLOGY (2011)

Article Clinical Neurology

Does lithium protect against dementia?

Lars Vedel Kessing et al.

BIPOLAR DISORDERS (2010)

Article Biochemistry & Molecular Biology

Calcium Signaling and Amyloid Toxicity in Alzheimer Disease

Angelo Demuro et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Psychology, Clinical

Lithium Trial in Alzheimer's Disease: A Randomized, Single-Blind, Placebo-Controlled, Multicenter 10-Week Study

Harald Hampel et al.

JOURNAL OF CLINICAL PSYCHIATRY (2009)

Review Neurosciences

Crosstalk between Cdk5 and GSK3 beta: implications for Alzheimer's disease

Olivia Engmann et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2009)

Article Psychiatry

Lithium Treatment and Risk of Dementia

Lars Vedel Kessing et al.

ARCHIVES OF GENERAL PSYCHIATRY (2008)

Article Pharmacology & Pharmacy

The role of GSK-3 in synaptic plasticity

S. Peineau et al.

BRITISH JOURNAL OF PHARMACOLOGY (2008)

Article Biochemistry & Molecular Biology

A polymorphism in CALHM1 influences Ca2+ homeostasis, Aβ levels, and Alzheimer's disease risk

Ute Dreses-Werringloer et al.

Review Neurosciences

Local protein synthesis, actin dynamics, and LTP consolidation

Clive R. Bramham

CURRENT OPINION IN NEUROBIOLOGY (2008)

Review Neurosciences

Concepts of neural nitric oxide-mediated transmission

John Garthwaite

EUROPEAN JOURNAL OF NEUROSCIENCE (2008)

Article Clinical Neurology

Lithium treatment decreases activities of tau kinases in a murine model of senescence

Marta Tajes et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)

Article Clinical Neurology

Lithium, a potential protective drug in Alzheimer's disease

T. Engel et al.

NEURODEGENERATIVE DISEASES (2008)

Review Neurosciences

Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease

Ilya Bezprozvanny et al.

TRENDS IN NEUROSCIENCES (2008)

Review Neurosciences

Chronic lithium treatment magnifies learning in rats

C. Nocjar et al.

NEUROSCIENCE (2007)

Review Clinical Neurology

The pathogenesis of alzheimers disease - Is it a lifelong Calciumopathy?

Grace E. Stutzmann

NEUROSCIENTIST (2007)

Article Biochemistry & Molecular Biology

Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories

S. A. Heldt et al.

MOLECULAR PSYCHIATRY (2007)

Article Pharmacology & Pharmacy

Effects of subchronic lithium treatment on levels of BDNF, Bcl-2 and phospho-CREB in the rat hippocampus

Michael D. Hammonds et al.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2007)

Article Psychiatry

Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder

Paula V. Nunes et al.

BRITISH JOURNAL OF PSYCHIATRY (2007)

Article Neurosciences

UP inhibits LTD in the hippocampus via regulation of GSK3β

Stephane Peineau et al.

NEURON (2007)

Article Neurosciences

Glycogen synthase kinase-3 inhibition is integral to long-term potentiation

Claudie Hooper et al.

EUROPEAN JOURNAL OF NEUROSCIENCE (2007)

Article Psychiatry

Does long-term medication with lithium, clozapine or antidepressants prevent or attenuate dementia in bipolar and depressed patients?

Jules Angst et al.

INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2007)

Article Oncology

Lithium treatment prevents neurocognitive deficit resulting from cranial irradiation

Eugenia M. Yazlovitskaya et al.

CANCER RESEARCH (2006)

Article Biochemistry & Molecular Biology

The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation

Florian Plattner et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Review Clinical Neurology

Lithium and dementia: A preliminary study

Takeshi Terao et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)

Article Biochemistry & Molecular Biology

Nitric oxide induces tau hyperphosphorylation via glycogen synthase kinase-3β activation

YH Zhang et al.

FEBS LETTERS (2005)

Article Multidisciplinary Sciences

Tau suppression in a neurodegenerative mouse model improves memory function

K SantaCruz et al.

SCIENCE (2005)

Article Biochemistry & Molecular Biology

Bidirectional regulation of neuronal nitric-oxide synthase phosphorylation at serine 847 by the N-methyl-D-aspartate receptor

GA Rameau et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Article Biochemistry & Molecular Biology

Cdk5, a therapeutic target for Alzheimer's disease?

LH Tsai et al.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2004)

Article Biochemistry & Molecular Biology

A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons

G Morfini et al.

EMBO JOURNAL (2004)

Article Pharmacology & Pharmacy

Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes

RS Jope

TRENDS IN PHARMACOLOGICAL SCIENCES (2003)

Article Multidisciplinary Sciences

GSK-3α regulates production of Alzheimer's disease amyloid-β peptides

CJ Phiel et al.

NATURE (2003)

Article Biochemistry & Molecular Biology

Lithium enhances long-term potentiation independently of hippocampal neurogenesis in the rat dentate gyrus

H Son et al.

JOURNAL OF NEUROCHEMISTRY (2003)

Article Biochemistry & Molecular Biology

Chronic lithium enhances hippocampal long-term potentiation, but not neurogenesis, in the aged rat dentate gyrus

IT Yu et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)

Article Neurosciences

Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model

Mar Perez et al.

JOURNAL OF ALZHEIMERS DISEASE (2003)

Review Clinical Neurology

Mood stabilizer psychopharmacology

TD Gould et al.

CLINICAL NEUROSCIENCE RESEARCH (2002)

Article Biochemistry & Molecular Biology

Truncation of CDK5 activator p35 induces intensive phosphorylation of Ser202/Thr205 of human tau

M Hashiguchi et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Article Biochemistry & Molecular Biology

BDNF-mediated signal transduction is modulated by GSK3β and mood stabilizing agents

L Mai et al.

JOURNAL OF NEUROCHEMISTRY (2002)

Article Neurosciences

A beta PP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576

Carola Otth et al.

JOURNAL OF ALZHEIMERS DISEASE (2002)